Slawek Deepika, Altshuler Diana, Dubrovskaya Yanina, Louie Eddie
Division of Infectious Diseases, NYU Langone Medical Center, New York, New York.
Department of Pharmacy, NYU Langone Medical Center, New York, New York.
Open Forum Infect Dis. 2017 Oct 7;4(4):ofx184. doi: 10.1093/ofid/ofx184. eCollection 2017 Fall.
Treatment of Legionnaires' disease in severely ill or immunosuppressed patients presents a clinical challenge. Tigecycline (TG) achieves high concentrations intracellularly and has been shown to be effective against in animal and cell models. We report our experience using TG as second-line therapy. Clinical response was seen in most patients after switching to TG alone or as a combination therapy.
对重症或免疫抑制患者的军团病进行治疗是一项临床挑战。替加环素(TG)在细胞内可达到高浓度,并且在动物和细胞模型中已显示出对(原文此处似乎缺失部分内容)有效。我们报告了使用TG作为二线治疗的经验。在改用单独使用TG或联合治疗后,大多数患者出现了临床反应。